We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

FOXO Technologies Inc (FOXO) USD0.0001 A

Sell:$0.23 Buy:$0.23 Change: $0.004 (1.70%)
Market closed |  Prices as at close on 23 July 2024 | Switch to live prices |
Change: $0.004 (1.70%)
Market closed |  Prices as at close on 23 July 2024 | Switch to live prices |
Change: $0.004 (1.70%)
Market closed |  Prices as at close on 23 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

FOXO Technologies Inc. is a biotechnology company. The Company is focused on improving human health and longevity through the development of cutting-edge technology and product solutions for various industries, including life insurance. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. Its FOXO Labs segment performs research and development and is commercializing proprietary epigenetic biomarker technology. Its concentrating efforts on Bioinformatics Services offering, a suite of bioinformatic tools to help researchers process, analyze, and interpret epigenetic data and research and development in the fields of health and wellness testing powered by machine learning and AI (including a potential AI platform for the delivery of health and well-being data-driven insights to individuals, healthcare professionals and third-party service providers).

Contact details

729 Washington Ave. N, Suite 600
United States
+1 (612) 5629447

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$2.83 million
Shares in issue:
11.28 million
Application Software
United States
US dollar

Key personnel

  • Mark White
    Interim Chief Executive Officer, Director
  • Martin Ward
    Interim Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.